Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-08
2005-11-08
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S352000, C514S353000, C514S357000, C514S406000, C514S412000, C514S443000, C514S447000, C514S469000, C514S604000, C546S153000, C546S307000, C546S312000, C548S362500, C548S469000, C548S509000, C549S057000, C549S068000, C549S404000, C564S091000, C564S092000
Reexamination Certificate
active
06962929
ABSTRACT:
The invention provides methods and compositions relating to novel pentafluorophenylsulfonamide derivatives and analogs and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, vascular restenosis, microbial infections, and psoriasis, or as lead compounds for the development of such agents. The compositions include compounds of the general formula I:
REFERENCES:
patent: 1955207 (1934-04-01), Stotter et al.
patent: 2402623 (1946-06-01), Hester et al.
patent: 3034955 (1962-05-01), Frick et al.
patent: 4443477 (1984-04-01), Witte et al.
patent: 4881969 (1989-11-01), Saupe et al.
patent: 4883914 (1989-11-01), Alvarado et al.
patent: 4900867 (1990-02-01), Wilkes et al.
patent: 5093340 (1992-03-01), Mohrs et al.
patent: 5250549 (1993-10-01), Yoshino et al.
patent: 5385931 (1995-01-01), Bigg et al.
patent: 5387709 (1995-02-01), Lardy et al.
patent: 5591503 (1997-01-01), Pews et al.
patent: 5610320 (1997-03-01), Yoshino et al.
patent: 5773236 (1998-06-01), Diwu et al.
patent: 5880151 (1999-03-01), Medina et al.
patent: 5891917 (1999-04-01), Tang et al.
patent: 6121304 (2000-09-01), Flygare et al.
patent: 6153585 (2000-11-01), Rubenstein et al.
patent: 6284923 (2001-09-01), Medina et al.
patent: 6316484 (2001-11-01), Flygare et al.
patent: 6355628 (2002-03-01), Schwendner et al.
patent: 6388131 (2002-05-01), Medina et al.
patent: 6482860 (2002-11-01), Flygare et al.
patent: 6521658 (2003-02-01), Li et al.
patent: 6630513 (2003-10-01), Rubenstein et al.
patent: 2002/0143036 (2002-10-01), Flygare et al.
patent: 2002/0177548 (2002-11-01), Schwendner et al.
patent: 3623184 (1992-02-01), None
patent: 0391799 (1990-10-01), None
patent: 91307061.1 (1991-01-01), None
patent: 0 469 901 (1992-02-01), None
patent: 472 449 (1992-02-01), None
patent: 0472499 (1992-02-01), None
patent: WO 97/30677 (1994-04-01), None
patent: 1242057 (1971-08-01), None
patent: 1306564 (1973-02-01), None
patent: WO 99/24407 (1999-05-01), None
U.S. Appl. No. 08/605,431, filed Feb. 22, 1996, Flygare et al.
March, J.,Advanced Organic Chemistry, 4th Edition, John Wiley & Sons, p. 497 (1992).
Yoshimoto, M., et al., “Correlation analysis of Baker's studies on enzyme inhibition, 2. Chymotrypsin, trypsin, thymidine phosphorylase, uridine phosphorylase, thymidylate synthetase, cylosine nucleoside deaminase, dihydrofolate reductase, malate dehydrogenase, glutamate dehydrogenase, lactate dehydrogenase, and glyceraldehydes-phosphate dehydrogenase” J. Med. Chem. 19(1):71-98 (1976).
Ishii et al., “Silver halide color photographic material containing magenta coupler” CAPLUS Abstract 108:177077 (1988).
Iwata et al., “Preparation of thiazolidine derivatives as platelet-activating factor antagonists” CAPLUS Abstract 116:214490 (1992).
Nazareth et al., “Electrophore-labeling and alkylation of standards of nucleic acid pyrimidine bases for analysis by gas chromatography with electron-capture detection” CAPLUS Abstract 102:109290 (1985).
Posner et al., “Diels-alder cycloadditions using electrophilic sulfonyl pyridones” CAPLUS Abstract 107:23211 (1987).
Fielding, et al.; “Synthesis and reactions of 4-sulpho-2,3,5,6,-tetrafluorobenzoic acid”,Journal of Fluorine Chemistry, Oct. 1992, vol. 59, No. 1, pp. 15-31.
Raibekas, et al.; “Affinity Probing of Flavin Binding Sites. 2. Identification of a Reactive Cysteine in the Flavin Domain ofEscherichia coliDNA Photolyase”;Biochemistry1994, vol. 33, No. 42, pp. 12656-12664.
Shealy, et al.; “2-Haloethylating Agents for Cancer Chemotherapy. 2-Haloethyl Sulfonates”;Journal of Medicinal Chemistry, Aug. 1983, vol. 26, No. 8, pp. 1168-1173.
Olander, et al.; “A Study of the Binding of Two Sulfonamides to Carbonic Anhydrase”;Journal of the American Chemical Society, Mar. 1973, vol. 95, No. 5, pp. 1616-1621.
Hawkinson, et al.; “Studies of the Solvolysis of2-Adamantyl Pentafluorobenzenesulfonate: AYpfbsScale1”;The Journal of Organic Chemistry, Aug., 1988, vol. 53, No. 16, pp. 3857-3860.
Bai, et al.; “Identification of the Cysteine Residue of β-Tubulin Alkylated by the Antimitotic Agent 2,4-Dichlorobenzyl Thiocyanate, Facilitated by Separation of the Protein Subunits of Tubulin by Hydrophobic Column Chromatography”;Biochemistry1989, vol. 28, pp. 5606-5612.
Fadeeva, V.P., et al., “Gas-chromatographic separation of sulfur-and fluorine-containing pyrolysis products”,Chemical Abstracts, 76:(5) (Jan. 31, 1972).
Gerig et al., “Aromatic Ring Dynamics in a Carbonic Anhydrase-Inhibitor Complex”,Journal of the Chemical Society Chemical Communications, No. 6, pp 482-484 (1987).
Luduena, E.F., et al. Interaction of Ethacrynic Acid with Bovine Brain Tubulin,Biochemical Pharmacology, 47:(9) 1677-1681 (Apr. 29, 1994).
Clark David Louis
Flygare John A.
Medina Julio Cesar
Rosen Terry J.
Shan Bei
O'Sullivan Peter
Tularik Inc.
LandOfFree
Pentafluorobenzenesulfonamides and analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pentafluorobenzenesulfonamides and analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pentafluorobenzenesulfonamides and analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3469300